GORDONMD GLOBAL INVESTMENTS LP enters PYXIS ONCOLOGY, INC. with 10.02M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 7/10/2026ACC: 0000919574-26-004386
10% Owner
Since Jun 2026
10.02M
Baseline shares
0.00
Direct ownership
0 positions
4.90M
Derivative underlying
1 instrument
1
Security positions
10.02M indirect
Non-Derivative Holdings1
Common Stock, par value $0.001 per share
IndirectShares owned10.02M
Total
10.02M indirect10.02M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.001 per share | 10.02M | Indirect |
| Total | 10.02M | 10.02M indirect |
Derivative Holdings1
Common Stock Purchase Warrant
DirectUnderlying security
Common Stock, par value $0.001 per share
Underlying shares
4.90M
Shares owned
N/A
Exercise price
3.289
Expiration
—
Exercise window
—
Total
Underlying
4.90M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Common Stock Purchase Warrant Direct | Common Stock, par value $0.001 per share | 3.289 | — | — | 4.90M | N/A |
| Total | 4.90M | 0.00 | ||||